Benchmark Initiates Coverage on Ceradyne (CRDN) with a Hold; Growing Solar Unlikely to Offset Deceleration in Body Armor
Tweet Send to a Friend
Benchmark initiates coverage on Ceradyne (Nasdaq: CRDN) with a Hold rating and price target of $20.
Benchmark analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


